Question-and-Answer Session
Operator
Thank you, sir. (Operator instructions) Our first question today is coming from the line of Ted Kundtz with Needham & Co. Please proceed with your question, sir.
Ted Kundtz – Needham & Co.
Thanks. Hello, Alan and Jim. Great to see a terrific quarter. Could you talk a little bit about – just looking forward, the incineration utilization issue? It was extremely high this quarter. What about scheduled maintenance going forward? What are you looking at in terms of that?
Alan McKim
I would say probably an extended shutdown in one of our smaller sites in Canada as we rebuild one of our plants up there, and that’ll be starting effective June 1. But I would say that the negative EBITDA from that one month would be about $400,000 for the company, and that's in our guidance.
Ted Kundtz – Needham & Co.
Okay.
Alan McKim
But the remaining of our plants are basically scheduled through their normal shutdown work for the year.
Ted Kundtz – Needham & Co.
Okay. So, nothing new will jump in the quarter there?
Alan McKim
That's right, other than Canada.
Ted Kundtz – Needham & Co.
Terrific. Secondly, just about landfill guidance. Could you give us a little more color as to what drove growth there?
Alan McKim
Our Canadian landfills were seasonally soft. With the weather and the frozen temperatures up there, if you would, we just didn't see a lot of remediation in landfill volume. But in the U.S., particularly in our West Coast landfills, we saw some nice strong project growth and some strong base business growth there. So, we are excited about some opportunities that we are seeing in Canada, so we think our second and third quarter volumes will pick up like historical, and that our U.S. volumes will continue to be pretty strong this year.
Ted Kundtz – Needham & Co.
Okay. Is there any particular what's driving the volume increase out West? Is it gaining market share? Any particular big contracts you're winning or what –?
Alan McKim
No, nothing. I wouldn't say anything very particular. As we noted in our call, our pharmaceutical business – excuse me, our Refinery business was very strong in chemical, and part of our revenue growth was associated with some project in remediation work that we are getting from refinery spending, but nothing out of the ordinary that you wouldn't see on an ongoing basis.
- To read the full transcript on Seeking Alpha, click here »
